Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001235802-11-000025
Filing Date
2011-01-21
Accepted
2011-01-21 12:21:12
Documents
1
Period of Report
2011-01-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3036
  Complete submission text file 0001235802-11-000025.txt   4926
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 111 BARCLAY BLVD SUITE 280 LINCOLNSHIRE IL 60069
Business Address
DONENBERG PHILIP B (Reporting) CIK: 0001238120 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 11540691